Cogent Biosciences (COGT) is up 135.0%, or $20.00 to $34.82.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COGT:
- Cogent Biosciences’ Phase 3 PEAK Study Success Positions Company for Market Leadership and $1.1 Billion Peak Sales
- Cogent upgraded to Buy at Stifel after ‘overwhelmingly positive’ GIST data
- Cogent Biosciences upgraded to Buy from Hold at Stifel
- Wedbush upgrades Cogent to Outperform after better-than-expected trial results
- Cogent Biosciences upgraded to Outperform from Neutral at Wedbush
